For example, systemic administration of recombinant human erythropoietin (EPO) or an increased EPO level through hypoxia induction protected photoreceptor cells in a mouse model of light-induced retinal degeneration (Grimm et al., 2004). This evidence concerns the gene EPO and retinal degeneration.